Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EIF4EBP1 | Q13541 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22866517 | 1.00 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL29650585 | 0.95 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL29650467 | 0.94 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL29650584 | 0.94 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL29661934 | 0.93 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| Water SCHEMBL27165018 | 0.93 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL22866515 | 0.93 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| Water SCHEMBL29885546 | 0.93 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL29650517 | 0.92 | EIF4EBP1 (1.00) | EIF4EBP1 | |
| SCHEMBL29650458 | 0.92 | EIF4EBP1 (1.00) | EIF4EBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4267586-A1 | SOLID FORMS OF AN EIF4E INHIBITOR | Pfizer Inc. (US) | 2023-11-01 | — | — | EP | disclosed |
| WO-2022137174-A1 | SOLID FORMS OF AN EIF4E INHIBITOR | PFIZER INC. (US) | 2022-06-30 | — | — | WO | disclosed |
| EP-3993875-A1 | METHODS OF TREATING BRAF-MUTATED CANCER CELLS | EFFECTOR THERAPEUTICS, INC. (US) | 2022-05-11 | — | — | EP | disclosed |
| EP-3994139-A1 | EIF4E-INHIBITING 4-OXO-3,4-DIHYDROPYRIDO[3,4-D]PYRIMIDINE COMPOUNDS | Effector Therapeutics Inc. (US) | 2022-05-11 | — | — | EP | disclosed |